|
US3879554A
(en)
*
|
1970-03-20 |
1975-04-22 |
Farmaceutici Italia |
Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
|
|
NL159384B
(nl)
*
|
1971-03-13 |
1979-02-15 |
Farmaceutici Italia |
Werkwijze voor het bereiden van een geneesmiddel met een adrenolytische activiteit, alsmede werkwijze voor het bereiden van een ester van 1-methyl-10-methoxylumilysergol.
|
|
DE2330912C3
(de)
*
|
1972-06-22 |
1979-01-11 |
Societa Farmaceutici Italia S.P.A., Mailand (Italien) |
Verfahren zur Herstellung von Bromergolinverbindungen
|
|
NL7400790A
(de)
*
|
1973-02-02 |
1974-08-06 |
|
|
|
US3996228A
(en)
*
|
1973-12-21 |
1976-12-07 |
Societa' Farmaceutici Italia S.P.A. |
Pyrimidinoaminoethyl ergoline derivatives
|
|
US3929796A
(en)
*
|
1974-08-02 |
1975-12-30 |
Lilly Co Eli |
Synthesis of penniclavine and elymoclavine
|
|
US4199579A
(en)
*
|
1975-03-14 |
1980-04-22 |
Siphar S. A. |
Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
|
|
US4054567A
(en)
*
|
1975-08-11 |
1977-10-18 |
Eli Lilly And Company |
6-Methyl-8β-hydroxymethyl-8-γ-substituted-9-ergolene compounds
|
|
US4082753A
(en)
*
|
1976-02-17 |
1978-04-04 |
Eli Lilly And Company |
Penniclavine acetonide
|
|
YU40004B
(en)
*
|
1977-07-21 |
1985-06-30 |
Lek Tovarna Farmacevtskih |
Praocess for preparing n-substituted esters of 9,10-dihydrlysergic acid
|
|
IT1094965B
(it)
*
|
1978-04-05 |
1985-08-10 |
Corvi Mora E |
Procedimento di preparazione di derivati del lisergolo
|
|
US4382940A
(en)
*
|
1979-12-06 |
1983-05-10 |
Farmitalia Carlo Erba S.P.A. |
Ercoline derivatives and therapeutic compositions having CNS affecting activity
|
|
IT1173489B
(it)
*
|
1984-03-27 |
1987-06-24 |
Inverni Della Beffa Spa |
Procedimento di preparazione di 1-metil-10alfa-metossilumilisergolo e di suci esteri,e intermedi per la loro preparazione
|
|
IT1213206B
(it)
*
|
1984-08-07 |
1989-12-14 |
Inverni Della Beffa Spa |
Procedimento per la preparazione di derivati del lisergolo.
|
|
HU193782B
(en)
*
|
1985-06-21 |
1987-11-30 |
Richter Gedeon Vegyeszet |
Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
|
|
FR2584720B1
(fr)
*
|
1985-07-11 |
1987-10-02 |
Rhone Poulenc Sante |
Procede de preparation de derives n-methyles de l'ergoline
|
|
FR2584719B1
(fr)
*
|
1985-07-11 |
1987-10-02 |
Rhone Poulenc Sante |
Procede de preparation des derives n-methyles du lysergol et du methoxy-10a lumilysergol
|
|
FR2584721B1
(fr)
*
|
1985-07-11 |
1987-10-02 |
Rhone Poulenc Sante |
Procede de preparation des derives n-methyles du dihydrolysergate de methyle ou du methoxylumilysergate de methyle
|
|
US4713385A
(en)
*
|
1985-10-01 |
1987-12-15 |
Eli Lilly And Company |
Alkoxy and dialkoxyalkyl esters of dihydrolysergic acid and related compounds useful as 5HT receptor antagonists
|
|
US4683237A
(en)
*
|
1985-12-20 |
1987-07-28 |
Eli Lilly And Company |
Fluoroalkyl esters of dihydrolysergic acid useful as 5HT2 receptor antagonists
|
|
US5211504A
(en)
*
|
1991-01-31 |
1993-05-18 |
Roger Trudel |
Adjustable manhole top
|
|
FR2786100B1
(fr)
|
1998-11-24 |
2002-03-01 |
Aventis Laboratoire |
Nouvelle application therapeutique de la nicergoline
|
|
FR2786101B1
(fr)
|
1998-11-24 |
2002-07-05 |
Aventis Laboratoire |
Utilisation de la nicergoline dans le traitement de la spasticite
|
|
OA12905A
(en)
|
2002-08-19 |
2006-10-13 |
Pfizer Prod Inc |
Combination therapy for hyperproliferative diseases.
|
|
US20050037063A1
(en)
*
|
2003-07-21 |
2005-02-17 |
Bolton Anthony E. |
Combined therapies
|
|
US20060063803A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Pfizer Inc |
4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
US8383660B2
(en)
|
2006-03-10 |
2013-02-26 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
|
US7919506B2
(en)
|
2006-03-10 |
2011-04-05 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
|
WO2008070496A2
(en)
|
2006-12-01 |
2008-06-12 |
Bristol-Myers Squibb Company |
N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
|
RU2618628C1
(ru)
|
2013-04-17 |
2017-05-05 |
Пфайзер Инк. |
Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
CA3125765A1
(en)
|
2019-01-18 |
2020-07-23 |
Astrazeneca Ab |
Pcsk9 inhibitors and methods of use thereof
|